A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
about
Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseUsing animal models to determine the significance of complement activation in Alzheimer's diseaseTargeting innate immunity for neurodegenerative disorders of the central nervous systemThe Rationale for Insulin Therapy in Alzheimer's DiseaseWho fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathwaysHospitalization and cognitive decline: Can the nature of the relationship be deciphered?Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapyFunctional Impact of Corticotropin-Releasing Factor Exposure on Tau Phosphorylation and Axon TransportInflammatory process in Alzheimer's DiseaseEffect of steroidal and non-steroidal drugs on the microglia activation pattern and the course of degeneration in the retinal degeneration slow mouseLow dose aspirin and cognitive function in the women's health study cognitive cohortNeuroinflammation in Alzheimer's diseaseNo effect of one-year treatment with indomethacin on Alzheimer's disease progression: a randomized controlled trialNeuroimaging in Alzheimer's disease: relevance for treatment.Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.The role of biomarkers in clinical trials for Alzheimer diseaseInterpreting biomarker data in therapeutic trials.Agreement in cognitive and clinical assessments in Alzheimer's disease.Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease.Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.Current treatment and recent clinical research in Alzheimer's diseasePreventing dementia.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014Pharmacological strategies for the prevention of Alzheimer's disease.Prevention of cognitive impairment in the midlife womenPharmacotherapy in the treatment of Alzheimer's disease: an updatePharmacotheraphy for Alzheimer's disease.Is pharmacological prevention of Alzheimer's a realistic goal?High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.Inflammation, apoptosis, and Alzheimer's disease.Prevention of Alzheimer's disease: where we stand.Anti-inflammatory agents in Alzheimer's disease.Does analysis using "last observation carried forward" introduce bias in dementia research?Neuroinflammation in Alzheimer's disease and prion disease.Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease.Risk factors for Alzheimer's disease: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment.Independent contributions of neural and "higher-order" deficits to symptoms in Alzheimer's disease: a latent variable modeling approach.Frontiers in Alzheimer's disease therapeutics.
P2860
Q24203739-5A69CED1-E546-49DF-BA31-670BF99BD94EQ24796236-E9FB6FDD-9F2D-4BB0-ACC4-ED8A2D7B4005Q26744219-CD425E74-4D23-4571-BBFE-20E98C19D211Q26744834-B974B4D9-8E65-4BDA-97EB-70709C7DE06DQ26830542-7CEB6375-5F50-4474-9FB2-D31CD7915CFEQ26851206-AE252807-B068-4537-A1B0-B16606CE9CEBQ27014919-667BB3F4-DCD4-4CD5-BF56-2FC475B933AAQ27329404-CFE23B10-9D98-425B-A64C-2709FF869283Q27500412-B3188141-9436-442B-B34B-D6EC203F6B01Q28218509-C8BB5A0C-256E-4A23-B52E-F22FE59402AFQ28222610-09A726C1-3D74-41CF-A94C-8E3D77987B09Q28259238-5B40FA38-F5F8-47C7-ABEF-BBDE43B76FBDQ28471970-D009A7AF-9829-4C29-A24C-6132FF249C35Q30627959-CC962D68-0AE2-4560-8A24-29573602CF0AQ30754529-AEB9595B-BEE2-45F1-A0E0-00C38A9008A1Q31032781-C44B4A00-CC52-4E13-B764-92FA6B3CFEE2Q33419934-D683F11B-F9D3-4D75-8140-D32A8AD14336Q33646545-708C0844-E254-4616-BC4B-9D56FA25A43FQ33745149-CBC2D84C-338D-4815-A6D5-E4F85AABF093Q33955075-7DB82E3A-0EE1-48CA-8B71-96C331AA7EDBQ34067487-811E02AF-429D-4FF5-9066-9F2EE8024D83Q34174220-1A0886F2-AF9E-48A2-9FBB-B744D487373CQ34222721-0AF9A01F-1292-48DF-98ED-2361A2453547Q34315588-8DCAC80D-5404-49B8-9DEF-9A6C633FA28FQ34408888-952A5CD1-7C7B-4DC2-B868-1A84DFF614E3Q34478669-321E6056-6552-4AB3-A547-A5F8F315548AQ34479407-0E19670A-D42D-4E58-B6FF-C17F57274427Q34481842-7F5BF556-CE53-48DE-A994-00341F2FCD1EQ34566556-EEC62B05-371A-4D0B-B842-58308ADE04F4Q34588663-BF749BE5-7659-4E77-8A6B-671220995D92Q34598450-A5C6B1C1-C29E-402D-9598-269C6F3F90F5Q34682170-90701AB0-8DD4-48A2-A14F-96A04861F4AFQ34778089-39759B17-06BF-4833-BE18-B88003B95257Q34778100-7AEFDB1E-EE39-4EDE-B9DE-125487E4167AQ34846882-C29749B0-870F-414B-AB30-06A22ECDD1A9Q34963776-DD70AAFA-8965-4140-99A4-CE18FE23350EQ34993154-2059D39D-7BF4-439C-815C-517040270F85Q35025023-28A0F468-190C-4C26-9840-C2131F0279D7Q35053648-C108C9C9-70E3-4035-958C-A6903249C358Q35086876-38ADACAF-7DEF-497C-AB91-8E5E02E5AAFD
P2860
A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A randomized controlled trial ...... r's Disease Cooperative Study.
@en
A randomized controlled trial ...... r's Disease Cooperative Study.
@nl
type
label
A randomized controlled trial ...... r's Disease Cooperative Study.
@en
A randomized controlled trial ...... r's Disease Cooperative Study.
@nl
prefLabel
A randomized controlled trial ...... r's Disease Cooperative Study.
@en
A randomized controlled trial ...... r's Disease Cooperative Study.
@nl
P2093
P356
P1433
P1476
A randomized controlled trial ...... r's Disease Cooperative Study.
@en
P2093
K Campbell
M F Weiner
M Grundman
M R Farlow
P304
P356
10.1212/WNL.54.3.588
P407
P577
2000-02-01T00:00:00Z